T cell repertoire diversity and clonotype follow-up in vaccination, cancer, infectious and
immune diseases represent a major challenge owing to the enormous complexity of the data
generated. Here we describe a next generation methodology, which combines 50
RACE PCR,
454 sequencing and, for analysis, IMGT, the international ImMunoGeneTics information
system (IMGT), IMGT/HighV-QUEST web portal and IMGT-ONTOLOGY concepts. The
approach is validated in a human case study of T cell receptor beta (TRB) repertoire, by
chronologically tracking the effects of influenza vaccination on conventional and regulatory
T cell subpopulations. The IMGT/HighV-QUEST paradigm defines standards for genotype/
haplotype analysis and characterization of IMGT clonotypes for clonal diversity and expression
and achieves a degree of resolution for next generation sequencing verifiable by the user
at the sequence level, while providing a normalized reference immunoprofile for human TRB.